{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:14:05Z","timestamp":1782562445330,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13550-015-0103-5","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T13:55:39Z","timestamp":1430315739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer"],"prefix":"10.1186","volume":"5","author":[{"given":"Azeem","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham E","family":"Searle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Huiban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Woodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Lowdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike R","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric O","family":"Aboagye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul C","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"issue":"20","key":"103_CR1","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, et al.: Metastatic behavior of breast cancer subtypes. J Clin Oncol 2010,28(20):3271\u20137. 10.1200\/JCO.2009.25.9820","journal-title":"J Clin Oncol"},{"issue":"14","key":"103_CR2","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1158\/1078-0432.CCR-10-2962","volume":"17","author":"AM Brufsky","year":"2011","unstructured":"Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D, et al.: Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res 2011,17(14):4834\u201343. 10.1158\/1078-0432.CCR-10-2962","journal-title":"Clin Cancer Res"},{"issue":"5","key":"103_CR3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.2910490504","volume":"49","author":"OP Kallioniemi","year":"1991","unstructured":"Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ: Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 1991,49(5):650\u20135. 10.1002\/ijc.2910490504","journal-title":"Int J Cancer"},{"issue":"4","key":"103_CR4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/dmd.107.018374","volume":"36","author":"JW Polli","year":"2008","unstructured":"Polli JW, Humphreys JE, Harmon KA, Castellino S, O\u2019Mara MJ, Olson KL, et al.: The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions. Drug Metab Dispos 2008,36(4):695\u2013701. 10.1124\/dmd.107.018374","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"103_CR5","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al.: Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007,27(9):1533\u20139. 10.1038\/sj.jcbfm.9600493","journal-title":"J Cereb Blood Flow Metab"},{"issue":"23","key":"103_CR6","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1200\/JCO.2005.16.584","volume":"23","author":"HA Burris 3rd","year":"2005","unstructured":"Burris HA 3rd, Hurwitz HI, Dees EC, Dowlati A, Blackwell KL, O\u2019Neil B, et al.: Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas. J Clin Oncol 2005,23(23):5305\u201313. 10.1200\/JCO.2005.16.584","journal-title":"J Clin Oncol"},{"issue":"2","key":"103_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuroimage.2005.09.057","volume":"30","author":"H Gu","year":"2006","unstructured":"Gu H, Lu H, Ye FQ, Stein EA, Yang Y: Noninvasive quantification of cerebral blood volume in humans during functional activation. Neuroimage 2006,30(2):377\u201387. 10.1016\/j.neuroimage.2005.09.057","journal-title":"Neuroimage"},{"issue":"3","key":"103_CR8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11095-011-0601-8","volume":"29","author":"KS Taskar","year":"2012","unstructured":"Taskar KS, Rudaraju V, Mittapalli RK, Samala R, Thorsheim HR, Lockman J, et al.: Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer. Pharm Res 2012,29(3):770\u201381. 10.1007\/s11095-011-0601-8","journal-title":"Pharm Res"},{"key":"103_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-genet-120213-092314","volume":"48","author":"M Gerlinger","year":"2014","unstructured":"Gerlinger M, McGranahan N, Dewhurst SM, Burrell RA, Tomlinson I, Swanton C: Cancer: evolution within a lifetime. Annu Rev Genet. 2014, 48: 215\u201336. 10.1146\/annurev-genet-120213-092314","journal-title":"Annu Rev Genet"},{"issue":"2","key":"103_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/neuonc\/nou141","volume":"17","author":"A Morikawa","year":"2015","unstructured":"Morikawa A, Peereboom DM, Thorsheim HR, Samala R, Balyan R, Murphy CG, et al.: Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study. Neuro Oncol 2015,17(2):289\u201395. 10.1093\/neuonc\/nou141","journal-title":"Neuro Oncol"},{"issue":"4","key":"103_CR11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1158\/1078-0432.CCR-08-1080","volume":"15","author":"NU Lin","year":"2009","unstructured":"Lin NU, Dieras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, et al.: Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res 2009,15(4):1452\u20139. 10.1158\/1078-0432.CCR-08-1080","journal-title":"Clin Cancer Res"},{"issue":"1","key":"103_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1470-2045(12)70432-1","volume":"14","author":"T Bachelot","year":"2013","unstructured":"Bachelot T, Romieu G, Campone M, Dieras V, Cropet C, Dalenc F, et al.: Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. Lancet Oncol 2013,14(1):64\u201371. 10.1016\/S1470-2045(12)70432-1","journal-title":"Lancet Oncol"},{"issue":"23","key":"103_CR13","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1158\/1078-0432.CCR-08-0415","volume":"14","author":"JR Molina","year":"2008","unstructured":"Molina JR, Kaufmann SH, Reid JM, Rubin SD, Galvez-Peralta M, Friedman R, et al.: Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data. Clin Cancer Res 2008,14(23):7900\u20138. 10.1158\/1078-0432.CCR-08-0415","journal-title":"Clin Cancer Res"},{"issue":"2","key":"103_CR14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/dmd.108.024646","volume":"37","author":"JW Polli","year":"2009","unstructured":"Polli JW, Olson KL, Chism JP, John-Williams LS, Yeager RL, Woodard SM, et al.: An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016). Drug Metab Dispos 2009,37(2):439\u201342. 10.1124\/dmd.108.024646","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"103_CR15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1189\/jlb.0203068","volume":"74","author":"F Leone","year":"2003","unstructured":"Leone F, Perissinotto E, Cavalloni G, Fonsato V, Bruno S, Surrenti N, et al.: Expression of the c-ErbB-2\/HER2 proto-oncogene in normal hematopoietic cells. J Leukoc Biol 2003,74(4):593\u2013601. 10.1189\/jlb.0203068","journal-title":"J Leukoc Biol"},{"key":"103_CR16","doi-asserted-by":"crossref","unstructured":"Pivot X, Manikhas A, Zurawski B, Chmielowska E, Karaszewska B, Allerton R, et al. CEREBEL (EGF111438): a phase III, randomized, open-label study of lapatinib plus capecitabine versus trastuzumab plus capecitabine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol. 2015. Epub: 2015\/01\/22.","DOI":"10.1200\/JCO.2014.57.1794"}],"updated-by":[{"DOI":"10.1186\/s13550-017-0325-9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000}},{"DOI":"10.1186\/s13550-017-0323-y","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000}}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-015-0103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-015-0103-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-015-0103-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:42:01Z","timestamp":1553640121000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ejnmmires.com\/content\/5\/1\/30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1186\/s13550-015-0103-5","relation":{"erratum":[{"id-type":"doi","id":"10.1186\/s13550-017-0325-9","asserted-by":"object"},{"id-type":"doi","id":"10.1186\/s13550-017-0323-y","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]},"article-number":"30"}}